These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Yap LB, Turner HE, Adams CB, Wass JA. Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243 [Abstract] [Full Text] [Related]
3. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB. Clin Endocrinol (Oxf); 1993 Jan; 38(1):79-86. PubMed ID: 8382119 [Abstract] [Full Text] [Related]
4. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF. Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748 [Abstract] [Full Text] [Related]
6. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B. Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [Abstract] [Full Text] [Related]
8. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease. Colombo P, Dall'Asta C, Barbetta L, Re T, Passini E, Faglia G, Ambrosi B. Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942 [Abstract] [Full Text] [Related]
9. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Comtois R, Beauregard H, Hardy J, Robert F, Somma M. Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915 [Abstract] [Full Text] [Related]
10. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery. Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K. Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103 [Abstract] [Full Text] [Related]
11. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy. Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F. J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430 [Abstract] [Full Text] [Related]
12. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease. Ohnishi T, Arita N, Yoshimine T, Mori S. Acta Neurochir (Wien); 2000 Nov; 142(8):855-64. PubMed ID: 11086823 [Abstract] [Full Text] [Related]
16. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Flitsch J, Knappe UJ, Lüdecke DK. Zentralbl Neurochir; 2003 Nov; 64(1):6-11. PubMed ID: 12582940 [Abstract] [Full Text] [Related]
17. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL. N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991 [Abstract] [Full Text] [Related]
18. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Colombo P, Passini E, Re T, Faglia G, Ambrosi B. Clin Endocrinol (Oxf); 1997 Jun 08; 46(6):661-8. PubMed ID: 9274696 [Abstract] [Full Text] [Related]
19. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, Benmiloud M. J Endocrinol Invest; 1996 Oct 08; 19(9):572-80. PubMed ID: 8957739 [Abstract] [Full Text] [Related]